A Faster, Simpler Way to Make Antibodies Using Bacteria.

What is it about?

A new bacterial method allows scientists to produce and purify functional antibodies in just a few days using standard laboratory equipment. This approach could reduce costs, speed up research and make antibody production more widely available around the world.

Featured Image

Why is it important?

Monoclonal antibodies are among the most important tools used in modern biological research, diagnostics and medicine. However, producing them typically requires mammalian cell culture, which is expensive, time-consuming and relies on specialised facilities. These practical barriers can limit access for many research laboratories and slow scientific progress. This study demonstrates a simple alternative by showing that functional monoclonal antibodies can be produced efficiently in Escherichia coli using the VNp protein production platform. Rather than requiring complex mammalian expression systems, the method enables bacteria to package correctly folded antibodies into protective membrane vesicles, from which they can be readily recovered while retaining their ability to recognise their target. The work is important because it extends the capabilities of the VNp platform beyond enzymes and other recombinant proteins to include structurally complex therapeutic proteins that were previously considered difficult to produce in bacteria. In doing so, it provides a faster, lower-cost and more accessible route for antibody production, with potential applications in research, diagnostics and biotechnology. The study also demonstrates the versatility of the VNp platform, highlighting its potential to transform recombinant protein production by making sophisticated biological reagents available to a much wider scientific community.